Home > Healthcare > Biotechnology > Biotechnology R&D > crispr and cas gene market
Get a free sample of CRISPR and Cas Gene Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of CRISPR and Cas Gene Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Major market players operating in the CRISPR and Cas gene market include
North America accounted for 42.3% share of the market in 2022 and is anticipated to foresee considerable growth through 2032 owing to the presence of well-established biotechnology and pharmaceutical sector in the region
The genome engineering application segment recorded 38.5% of the market share in 2022 driven by the rise in R&D activities demonstrating the effectiveness of CRISPR technologies
CRISPR and cas gene market size was USD 2.5 billion in 2022 and will reach USD 17.4 billion by end of 2032 due to high prevalence of genetic diseases and complex medical conditions worldwide
Biotechnology & pharmaceutical companies is projected to observe 21.2% CAGR from 2023-2032 owing to the rising number of partnerships and collaborations between academic researchers and industry players